Literature DB >> 2005205

Genetic factors in bone turnover.

P J Kelly1, J L Hopper, G T Macaskill, N A Pocock, P N Sambrook, J A Eisman.   

Abstract

Genetic factors are major determinants of adult bone density, however, it is unknown how these effects may be mediated. Since bone mineral density is the net result of bone formation and bone resorption we studied biochemical indices of bone formation (serum osteocalcin) and resorption [fasting urinary calcium:creatinine (Ca/Crt) and hydroxyproline:creatinine (OH/Crt)] in adult female twins; 39 monozygotic (MZ) and 31 dizygotic (DZ) twin pairs (age, mean +/- SEM, MZ: 51.1 +/- 1.5 yrs; DZ: 46.5 +/- 1.5 yrs, P = NS). Of these subjects, 18 MZ twin pairs and 10 DZ twin pairs were postmenopausal. The MZ twin pair correlations (rMZ) for each index of bone turnover exceeded that between DZ pairs (rDZ), but this difference was only significant for osteocalcin (rMZ = 0.81, rDZ = 0.21, P less than 0.001). Similarly, in the postmenopausal group examined alone, the rMZ (r = 0.84) for serum osteocalcin was significantly greater than rDZ (r = -0.003, P less than 0.03). These osteocalcin data imply that 80% of the variance in serum osteocalcin could be explained by genetic factors. Although genetic effects on fasting urinary hydroxyproline:creatine and calcium:creatinine were not demonstrable, these indices may be less precise and specific. The data indicate that circulating osteocalcin, and therefore bone formation, is strongly genetically determined. These studies suggest at least one of the mechanisms of the genetic effect on bone mass relates to the regulation of bone turnover.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2005205     DOI: 10.1210/jcem-72-4-808

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  27 in total

1.  Genetic analysis of serum osteocalcin and bone mineral in multigenerational Afro-Caribbean families.

Authors:  A L Kuipers; C Gundberg; C M Kammerer; A S Dressen; C S Nestlerode; A L Patrick; V W Wheeler; C H Bunker; A B Newman; J M Zmuda
Journal:  Osteoporos Int       Date:  2011-09-21       Impact factor: 4.507

Review 2.  Systems analysis of bone.

Authors:  Karl J Jepsen
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2009 Jul-Aug

3.  Influence of Vitamin D Receptor Gene Fok1 Polymorphism on Bone Mass Accrual Post Calcium and Vitamin D Supplementation.

Authors:  Neha Sanwalka; Anuradha Khadilkar; Shashi Chiplonkar; Kavita Khatod; Nikhil Phadke; Vaman Khadilkar
Journal:  Indian J Pediatr       Date:  2015-05-15       Impact factor: 1.967

4.  Association of primary biliary cirrhosis with vitamin D receptor BsmI genotype polymorphism in a Hungarian population.

Authors:  B Halmos; F Szalay; T Cserniczky; E Nemesanszky; P Lakatos; S Barlage; G Schmitz; L Romics; A Csaszar
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

Review 5.  Estrogen status and bone mass in the premenopausal period: is osteoporosis a developmental disease?

Authors:  R Civitelli; D T Villareal; R Armamento-Villareal
Journal:  J Endocrinol Invest       Date:  1993-11       Impact factor: 4.256

6.  Genetics of osteoporosis.

Authors:  M L Brandi; M L Bianchi; J A Eisman; F Glorieux; S Adami; C E Fiore; R Nuti; S Ortolani
Journal:  Calcif Tissue Int       Date:  1994-09       Impact factor: 4.333

7.  Family resemblance of bone turnover rate in mothers and daughters--the MODAM study.

Authors:  H Nagy; R Chapurlat; E Sornay-Rendu; S Boutroy; P Szulc
Journal:  Osteoporos Int       Date:  2014-12-19       Impact factor: 4.507

8.  Allelic variation at the interleukin 1beta gene is associated with decreased bone mass in patients with inflammatory bowel diseases.

Authors:  A Nemetz; M Tóth; M A García-González; T Zágoni; J Fehér; A S Peña; Z Tulassay
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

9.  Peak bone mass and osteoporosis prevention.

Authors:  J A Eisman; P J Kelly; N A Morrison; N A Pocock; R Yeoman; J Birmingham; P N Sambrook
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

10.  Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin.

Authors:  N A Morrison; R Yeoman; P J Kelly; J A Eisman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.